PORTO @ 
Archivio Istituzionale della Ricerca
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishMesoporous bioactive glasses (MBGs) have been extensively studied for bone applications. Their high surface area and tunable pore size allow the incorporation of therapeutic ions and drugs to impart specific biological functions. The incorporation of these carriers in a thermosensitive hydrogel, acting as vehicle phase, represents a strategy to release these therapeutic species in the pathological sites. The aim of this work is to design a hybrid platform based on MBGs containing strontium (inhibition of the osteoclast differentiation potential) and a Poloxamer 407-based poly(ether urethane) (PEU). In order to enhance the pro-osteogenic response, MBGs were also loaded with N-acetylcysteine (NAC).
Injectable hydrogel-mesoporous bioactive glass systems to deliver in situ therapeutic species for bone application / Bari, Alessandra; Pontremoli, Carlotta; Boffito, Monica; TONDA TURO, Chiara; Ciardelli, Gianluca; Torre, Elisa; Cassinelli, Clara; Iviglia, Giorgio; Fiorilli, SONIA LUCIA; VITALE BROVARONE, Chiara. - STAMPA. - (2018). ((Intervento presentato al convegno ESB 2018 (29th Annual Meeting of the European Society for Biomaterials) tenutosi a Maastricht nel 9-13 September 2018.
| Titolo: | Injectable hydrogel-mesoporous bioactive glass systems to deliver in situ therapeutic species for bone application | |
| Autori: | ||
| Data di pubblicazione: | 2018 | |
| Abstract: | Mesoporous bioactive glasses (MBGs) have been extensively studied for bone applications. Their high surface area and tunable pore size allow the incorporation of therapeutic ions and drugs to impart specific biological functions. The incorporation of these carriers in a thermosensitive hydrogel, acting as vehicle phase, represents a strategy to release these therapeutic species in the pathological sites. The aim of this work is to design a hybrid platform based on MBGs containing strontium (inhibition of the osteoclast differentiation potential) and a Poloxamer 407-based poly(ether urethane) (PEU). In order to enhance the pro-osteogenic response, MBGs were also loaded with N-acetylcysteine (NAC). | |
| Appare nelle tipologie: | 4.3 Poster |
File in questo prodotto:
http://hdl.handle.net/11583/2732147
Copyright © 2022